Tariffs should not influence decisions at Indian drug companies, Cipla's top executive said on Friday, as the industry braces ...

The US relies heavily on Indian generic medicines, with nearly half of all generic drugs consumed in the US originating from ...

If drug tariffs don’t work, they could result in higher prices for American patients and increase drug shortages. Testing ...

New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have ...

The Indian Pharmaceutical Alliance (IPA) has proposed reducing the import duty on pharma products from the US to zero.

The respiratory segment, often influenced by seasonal factors, registered a 1.1% increase in value but faced a 4.6% decline ...

The pharma sector export data for fourth quarter has been released. According to Phillip Capital, the latest export data ...

Indian Pharmaceuticals Market has delivered marginally lower revenue at 7.5% year on year in February 2025, compared to 8.7% ...